Anti-CDNF/ ARMETL1 functional antibody

Anti-CDNF/ ARMETL1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CDNF/CDNF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0754-Ab-1/ GM-Tg-hg-SE0754-Ab-2Anti-Human CDNF monoclonal antibodyHuman
GM-Tg-rg-SE0754-Ab-1/ GM-Tg-rg-SE0754-Ab-2Anti-Rat CDNF monoclonal antibodyRat
GM-Tg-mg-SE0754-Ab-1/ GM-Tg-mg-SE0754-Ab-2Anti-Mouse CDNF monoclonal antibodyMouse
GM-Tg-cynog-SE0754-Ab-1/ GM-Tg-cynog-SE0754-Ab-2Anti-Cynomolgus/ Rhesus macaque CDNF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0754-Ab-1/ GM-Tg-felg-SE0754-Ab-2Anti-Feline CDNF monoclonal antibodyFeline
GM-Tg-cang-SE0754-Ab-1/ GM-Tg-cang-SE0754-Ab-2Anti-Canine CDNF monoclonal antibodyCanine
GM-Tg-bovg-SE0754-Ab-1/ GM-Tg-bovg-SE0754-Ab-2Anti-Bovine CDNF monoclonal antibodyBovine
GM-Tg-equg-SE0754-Ab-1/ GM-Tg-equg-SE0754-Ab-2Anti-Equine CDNF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0754-Ab-1/ GM-Tg-hg-SE0754-Ab-2; GM-Tg-rg-SE0754-Ab-1/ GM-Tg-rg-SE0754-Ab-2;
GM-Tg-mg-SE0754-Ab-1/ GM-Tg-mg-SE0754-Ab-2; GM-Tg-cynog-SE0754-Ab-1/ GM-Tg-cynog-SE0754-Ab-2;
GM-Tg-felg-SE0754-Ab-1/ GM-Tg-felg-SE0754-Ab-2; GM-Tg-cang-SE0754-Ab-1/ GM-Tg-cang-SE0754-Ab-2;
GM-Tg-bovg-SE0754-Ab-1/ GM-Tg-bovg-SE0754-Ab-2; GM-Tg-equg-SE0754-Ab-1/ GM-Tg-equg-SE0754-Ab-2
Products NameAnti-CDNF monoclonal antibody
Formatmab
Target NameCDNF
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CDNF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0754-Ag-1Recombinant multi-species CDNF/ ARMETL1 protein
    ORF Viral VectorpGMLP004540human CDNF Lentivirus plasmid
    ORF Viral VectorvGMLP004540human CDNF Lentivirus particle
    ORF Viral VectorpGMLPm000295mouse Cdnf Lentivirus plasmid
    ORF Viral VectorvGMLPm000295mouse Cdnf Lentivirus particle


    Target information

    Target IDGM-SE0754
    Target NameCDNF
    Gene ID441549,227526,361276,697138,607252,101098963,513798,100056424
    Gene Symbol and Synonyms9330140G23,ARMETL1,CDNF
    Uniprot AccessionQ49AH0,P0C5I0
    Uniprot Entry NameCDNF_HUMAN,CDNF_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185267
    Target ClassificationN/A

    The target: CDNF, gene name: CDNF, also named as ARMETL1. Predicted to enable growth factor activity. Predicted to be involved in dopaminergic neuron differentiation and neuron projection development. Predicted to be active in endoplasmic reticulum and extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.